Rapid and robust identification of sepsis using SeptiCyte RAPID in a heterogenous patient population
R.A. Balk(Rush University Medical Center), Marcus J. Schultz(University of St.Gallen), Richard E. Rothman(Rush University Medical Center), Krupa Navalkar, Franco R. D’Alessio(University of Maryland, Baltimore), Jared A. Greenberg(Rush University Medical Center), Majid Afshar(Loyola University Medical Center), Peter M. C. Klein Klouwenberg(University Medical Center Utrecht), Jordan A. Kempker(Emory University), Brendon P. Scicluna(Academic Medical Center), Santhi Kumar(University of Southern California), Xue W. Mei(Princeton University), Russell R. Miller(JGC (Japan)), Jorge P. Parada(Loyola University Chicago), Janice M. Liebler(University of Southern California), Emily Gilbert(Loyola University Chicago)
Cited by 0
Related Papers
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults
|New England Journal of Medicine|2015|3.4k
Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein
|New England Journal of Medicine|1996|1.3k
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis
|Critical Care Medicine|1997|863
Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study
|The Lancet Respiratory Medicine|2017|645